Netherlands· NL-71ebee6cc41d

TRUSOPT conserveermiddelvrij, oogdruppels, oplossing in flacon voor eenmalig gebruik 20 mg/ml

A dorzolamide product containing dorzolamidehydrochloride, registered in Netherlands by Santen Oy. The same ATC class is registered in 19 of our 19 countries.

ATC S01EC03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about dorzolamidehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Dorzolamide is registered in 19 of 19 countries.

Countries holding a registration under ATC S01EC03 (dorzolamide), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search dorzolamide products by name

Dorzolamide · ATC S01EC03

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: DORZOLAMIDEHYDROCHLORIDE
Manufacturer: Santen Oy
Country: Netherlands (NL)
ATC code: S01EC03
ATC class: Dorzolamide
Defined daily dose: 0.3 ml, AT
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
32633

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for dorzolamide.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check dorzolamide against other medicines How interaction checks work

Dorzolamide · interactions on record

4 records

4 severe

Most severe, free to view

Acetylsalicylic acidB01AC06severe
Salicylic acidD01AE12severe
Acetylsalicylic acidN02BA01severe
Salicylic acidS01BC08severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dorzolamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dorzolamide products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Dorlazept, Dorzo-Vision
Belgium · Trusopt, Trusopt 2 % Unit Dose
Bulgaria · Дорзамед
Cyprus · Dorolad, Dorzon
Czechia · Dorzolamid Olikla, Dorzolamide Farmaprojects
Germany · Dimaz, Dorlazept
Denmark · Delazo, Dorzolamid Hexal
Estonia · Dorzolamide Elvim, Trusopt
Spain · Arzolan, Dimaz
Finland · Itoco, Odyral
France · Dorzolamide Arrow, Dorzolamide Bgr
United Kingdom (Northern Ireland) · Dimaz, Dorzolamide
Greece · Delazo, Dorolad
Croatia · Dorvis, Dorzol
Hungary · Dorzolep, Trusopt
Ireland · Itoco, Trusopt
Iceland · Dorzolamide Alvogen
Italy · Dorzoclar, Dorzolamide Aurobindo
Lithuania · Dorzolamide Actavis, Dorzolamide Elvim
Luxembourg · Dorzo-Vision, Trusopt 2 % Unit Dose
Latvia · Dorzolamide Actavis, Dorzolamide Elvim
Norway · Dimaz, Trusopt
Poland · Dorzostill, Nodofree
Portugal · Dimaz, Dorcil
Romania · Dorzolamidă Arena, Dorzopt
Sweden · Dimaz, Dorzolamid Hexal
Slovakia · Dorzolamid Olikla, Dozotens

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b7870776-7489-4a29-af26-bbfbc0d9b2fd
GET /v1/drugs/b7870776-7489-4a29-af26-bbfbc0d9b2fd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h32633_smpc.pdf",
  "strength": null,
  "atc_label": "Dorzolamide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg32633",
  "excipients": [
    "HYDROXYETHYLCELLULOSE",
    "MANNITOL (D-) (E 421)",
    "NATRIUMHYDROXIDE (E 524)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "DORZOLAMIDEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h32633.pdf",
  "authorised_at": "2006/01/23",
  "procedure_number": "FR/H/0070/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "32633",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about dorzolamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console